Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer Treatment Group N0147 (Alliance)

BACKGROUND. Preclinical and epidemiological data suggest that metformin might have antineoplastic properties against colon cancer (CC). However, the effect of metformin use on patient survival in stage III CC after curative resection is unknown. The survival outcomes were comparable regardless of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Preet Paul, Shi, Qian, Foster, Nathan R., Grothey, Axel, Nair, Suresh G., Chan, Emily, Shields, Anthony F., Goldberg, Richard M., Gill, Sharlene, Kahlenberg, Morton S., Sinicrope, Frank A., Sargent, Daniel J., Alberts, Steven R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2016
Materias:
Gastrointestinal Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153338/
https://www.ncbi.nlm.nih.gov/pubmed/27881709
http://dx.doi.org/10.1634/theoncologist.2016-0153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153338/
https://www.ncbi.nlm.nih.gov/pubmed/27881709
http://dx.doi.org/10.1634/theoncologist.2016-0153

Ejemplares similares